Skip to content

Assessment of Niacinamide Cosmetic Product Efficacy in Model of Irritant Contact Dermatitis

Randomized Controlled Trial of Niacinamide Cosmetic Product Efficacy in Model of Irritant Contact Dermatitis

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06331390
Enrollment
25
Registered
2024-03-26
Start date
2024-04-30
Completion date
2024-07-31
Last updated
2024-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Contact Dermatitis

Brief summary

Testing the effectiveness and safety of cosmetics with niacinamide in irritant contact dermatitis: A Randomised, Controlled Trial will be conducted at USSM. Healthy volunteers will be included (at least 25) and test sites are forearms. Sodium lauryl sulphate will be used to induce contact dermatitis and participants will be measured for 7 days

Detailed description

The efficacy of niacinamide cosmetic product on contact dermatitis will be evaluated using Courage Khazaka device and probes for hydration, redness and transepidermal water loss

Interventions

OTHERniacinamide cosmetic product

immortella skincare product

OTHERplacebo

nothing

Sponsors

University of Split, School of Medicine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* young, healthy volunteers who gave written informed consent

Exclusion criteria

* skin disease, skin damage on measurement sites, use of corticosteroids and immunomodulators a month prior to the inclusion and during the trial, non-adherence to the trial protocol, exposure to artificial UV radiation, pregnancy and lactation

Design outcomes

Primary

MeasureTime frameDescription
tewameterday 1- day 7measurement of transepidermal water loss on skin, objective and non invasive

Countries

Croatia

Contacts

Primary ContactJOSIPA BUKIĆ
jbukic@mefst.hr00385917933752

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026